BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31026731)

  • 1. Involvement of miR-665 in protection effect of dexmedetomidine against Oxidative Stress Injury in myocardial cells via CB2 and CK1.
    Yu J; Yang W; Wang W; Wang Z; Pu Y; Chen H; Wang F; Qian J
    Biomed Pharmacother; 2019 Jul; 115():108894. PubMed ID: 31026731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.
    Bian C; Xu T; Zhu H; Pan D; Liu Y; Luo Y; Wu P; Li D
    PLoS One; 2015; 10(12):e0144877. PubMed ID: 26658785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
    He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
    Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
    Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
    Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
    Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
    Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine protects PC12 cells from oxidative damage through regulation of miR-199a/HIF-1α.
    Wu L; Xi Y; Kong Q
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):506-514. PubMed ID: 32024386
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134.
    Li YJ; Zhang DZ; Xi Y; Wu CA
    Hum Exp Toxicol; 2021 Dec; 40(12):2145-2155. PubMed ID: 34121490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
    Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
    Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
    Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
    Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells.
    He Y; Yang Z; Li J; Li E
    Exp Mol Pathol; 2020 Apr; 113():104371. PubMed ID: 31917290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
    Zhang Y; Zhao Q; Li X; Ji F
    Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microRNA-184 reduces H2O2-mediated cardiomyocyte injury via targeting FBXO28.
    Zou JF; Wu XN; Shi RH; Sun YQ; Qin FJ; Yang YM
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11251-11258. PubMed ID: 33215444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine alleviates pulmonary ischemia-reperfusion injury through modulating the miR-21-5p/Nr4a1 signaling pathway.
    Dong W; Yang H; Cheng M; Zhang X; Yin J; Zeng Z; Huang G
    Acta Biochim Pol; 2020 Dec; 67(4):521-529. PubMed ID: 33332077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-22 contributes to myocardial ischemia-reperfusion injury by interfering with the mitochondrial function.
    Du JK; Cong BH; Yu Q; Wang H; Wang L; Wang CN; Tang XL; Lu JQ; Zhu XY; Ni X
    Free Radic Biol Med; 2016 Jul; 96():406-17. PubMed ID: 27174562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine alleviates H
    Yin W; Wang C; Peng Y; Yuan W; Zhang Z; Liu H; Xia Z; Ren C; Qian J
    Mol Biol Rep; 2020 May; 47(5):3629-3639. PubMed ID: 32342432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of miR-711 in cardiac cells in response to oxidative stress and its biogenesis: a study on H9C2 cells.
    Zhao D; Zheng H; Greasley A; Ling F; Zhou Q; Wang B; Ni T; Topiwala I; Zhu C; Mele T; Liu K; Zheng X
    Cell Mol Biol Lett; 2020; 25():26. PubMed ID: 32308692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-135a Regulates Apoptosis Induced by Hydrogen Peroxide in Rat Cardiomyoblast Cells.
    Liu N; Shi YF; Diao HY; Li YX; Cui Y; Song XJ; Tian X; Li TY; Liu B
    Int J Biol Sci; 2017; 13(1):13-21. PubMed ID: 28123342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine-up-regulated microRNA-381 exerts anti-inflammatory effects in rats with cerebral ischaemic injury via the transcriptional factor IRF4.
    Fang H; Li HF; Yan JY; Yang M; Zhang JP
    J Cell Mol Med; 2021 Feb; 25(4):2098-2109. PubMed ID: 33314611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-210 alleviates oxidative stress-associated cardiomyocyte apoptosis by regulating BNIP3.
    Diao H; Liu B; Shi Y; Song C; Guo Z; Liu N; Song X; Lu Y; Lin X; Li Z
    Biosci Biotechnol Biochem; 2017 Sep; 81(9):1712-1720. PubMed ID: 28661226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine attenuates H2O2-induced neonatal rat cardiomyocytes apoptosis through mitochondria- and ER-medicated oxidative stress pathways.
    Liu XR; Li T; Cao L; Yu YY; Chen LL; Fan XH; Yang BB; Tan XQ
    Mol Med Rep; 2018 May; 17(5):7258-7264. PubMed ID: 29568958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.